Conditions: Chronic Kidney Disease Dialysis Hyperphosphatemia Dyslipidemia
Keywords: Chronic Kidney Disease Dialysis Hyperphosphatemia Dyslipidemia Phosphate binder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 642
Healthy volunteers: no

Brief summary:
This is a phase III multi-centre study in two periods: the first period is a phosphate binder and lipid lowering drugs washout for 8 weeks, the second period is a double-blind, randomised, parallel group, fixed dose, for 12 weeks.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: MCI-196 intervention 2: Placebo
Intervention descriptions: intervention 1: 3g to 15g/day (3 times a day), Tablet, 12 weeks of fixed dose of study intervention 2: 3g to 15g/day (3 times a day), Tablet, 12 weeks of fixed dose of study

Protocol document: